RecruitingNANCT06887699

A Randomized Clinical Trial Investigating the Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value-Based Payment System

Sponsor: National Defense Medical Center, Taiwan

Trial Details

Condition	OMI - Occlusion Myocardial Infarction, Artificial Intelligence (AI), Electrocardiogram, Cost-effectiveness Analysis
Intervention	AI-ECG P4P program
Phase	NA
Status	Recruiting
Participants	212,000
Est. Completion	31 Mar 2028
Last Updated	9 Apr 2026

Primary Outcome

D-to-W time (Door to Wire Time); Cost Outcome Measure

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Patients in the emergency department * Patients received at least 1 ECG examination. Exclusion Criteria: * The patients received ECG at the period of inactive AI-ECG system. * Patients with a history of coronary angiography within the past 3 days.

Trial Sites

Countries

Taiwan

View Registry Entry

Related Analysis

Landmark Taiwan Trial Tests AI-ECG Integration in Value-Based Care for STEMI — 212,000 Patient Study Opens

A landmark 212,000-patient study in Taiwan is testing whether AI-ECG technology integrated with pay-for-performance incentives can improve STEMI diagnosis and reduce door-to-wire times. Results could reshape cardiac care delivery globally.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service